- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04213235
Educational Materials Development for Physical Activity in CAncer (EDuCA)
December 25, 2019 updated by: Alice Avancini, Universita di Verona
E.D.u.CA: a Guidebook to Increase Physical Activity Level in Cancer Patients
In cancer setting, physical exercise has emerged as an important factor to control cancer-related symptoms and improve patients' quality of life.
In addition, the correlation between physical activity and survival is recently consolidating.
Nevertheless, several previous studies have shown that the majority of cancer patients are insufficiently active.
Written information, for example a guidebook, may be a good oppurtunity, to improve lifestyle.
Developing and testing an exercise guidebook, based on Theory of Planned Behavior and specifically designed for cancer patients, may be an effective tool to deliver information and increase physical activity level in this population.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
25
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Alice Avancini
- Phone Number: 3403624264
- Email: alice.avancini@univr.it
Study Locations
-
-
-
Verona, Italy, 37131
- Recruiting
- University of Verona
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- signed informed consent;
- confirmed cancer diagnosis.
Exclusion Criteria:
- sufficient physical activity level.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Physical exercise
|
The participants will receive the written exercise guidebook and a counselling by kinesiologist.
Moreover, they will be instructed how to increase their physical activity level.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Physical activity level - using Godin's Leisure Time Exercise Questionnaire (GLTEQ)
Time Frame: Change from baseline physical activity level at 4 weeks
|
Change from baseline physical activity level at 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
quality of life - using European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire" (EORTC QLQ C-30)
Time Frame: Change from baseline physical activity level at 4 weeks
|
Change from baseline physical activity level at 4 weeks
|
Sedentary behavior - using Sedentary Behaviour Questionnaire (SBQ)
Time Frame: Change from baseline physical activity level at 4 weeks
|
Change from baseline physical activity level at 4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
January 1, 2020
Primary Completion (ANTICIPATED)
November 1, 2020
Study Completion (ANTICIPATED)
November 1, 2020
Study Registration Dates
First Submitted
December 25, 2019
First Submitted That Met QC Criteria
December 25, 2019
First Posted (ACTUAL)
December 30, 2019
Study Record Updates
Last Update Posted (ACTUAL)
December 30, 2019
Last Update Submitted That Met QC Criteria
December 25, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 67002
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mixed Cancer
-
Universita di VeronaActive, not recruiting
-
Montefiore Medical CenterCompletedUterine CancerUnited States
-
M.D. Anderson Cancer CenterCompletedMixed Tumor, MullerianUnited States
-
RenJi HospitalNot yet recruitingPediatric Cancer | Liver Cancer | Hepatoblastoma | Pediatric Solid Tumor | Transitional Cell TumorChina
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma | Mixed Tumor, MesodermalUnited States
-
Massachusetts General HospitalTerminatedMixed Venous Oxygen Saturation | Tissue OxygenationUnited States
-
M.D. Anderson Cancer CenterTerminatedUterine NeoplasmsUnited States
-
Guolin WangUnknownEtomidate is Mixed With PropofolChina
-
University of Alabama at BirminghamRecruitingCarcinoma | Gynecologic Cancer | Endometrial Cancer | Uterine CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Sanofi; Brigham and Women's HospitalCompletedMixed Mullerian Tumors of the UterusUnited States
Clinical Trials on Physical activity
-
Health Education Research Foundation (HERF)CompletedQuality of LifePakistan
-
Zohra Institute of Health SciencesCompletedPhysical Activity and StressPakistan
-
Centre Hospitalier Universitaire DijonWithdrawn
-
AUSL Romagna RiminiFondazione IRCCS Istituto Nazionale dei Tumori, MilanoRecruitingNon-Small Cell Lung CancerItaly
-
Fundación para la Investigación del Hospital Clínico...CompletedObesity | Severe Mental Disorder
-
Augusta UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Kansas... and other collaboratorsCompletedMental Disorders, SevereUnited States
-
Centre Hospitalier Departemental VendeeTerminated
-
Rio de Janeiro State UniversityCompleted
-
Cardenal Herrera UniversityRecruiting
-
Istituti Clinici Scientifici Maugeri SpAActive, not recruiting